A DREAM COME TRUE FOR THE ENTIE GENETIC SOCIETY.
The hard working and persistent Anne Wojcicki, the co-founder and CEO of one of the personal genomics company, 23andMe broke this amazing news to people who want to be more proactive and in control of their health;
The U.S. Food and Drug Administration granted 23andMe authorization to offer ten genetic health risk reports including late-onset Alzheimer’s disease, Parkinson’s disease, celiac disease, and a condition associated with harmful blood clots.
“The FDA has embraced innovation and has empowered people by authorizing direct access to this information,” said 23andMe co-founder and CEO Anne Wojcicki. “It is a significant step forward for 23andMe and for the adoption of personal genetics.”
Congratulations on this huge breakthrough!
By Megan Pormer